Article

A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV

2020-01-01

Abstract excerpt

Гинцбург А

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e4ac184-1076-55b1-941a-c09baab71340
DOI: 10.33029/0206-4952-2020-41-2-135-143

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoVDOI 10.33029/0206-4952-2020-41-2-135-143Read

Research progress and challenges to coronavirus vaccine developmentSemantic proximity Read

Vectored vaccines to protect against PRRSVSemantic proximity Read

Viral vectors for vaccine applicationsSemantic proximity Read

Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.Semantic proximity Read

Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirusSemantic proximity Read

Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in miceSemantic proximity Read

Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunitySemantic proximity Read

Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2Semantic proximity Read

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read

Infectious vaccines.Semantic proximity Read

The vaccines can keep up with the SARS-CoV-2 mutations.Semantic proximity Read

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read